These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 22526164

  • 1. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach.
    Steinmann D, Maertens B, Janssen S, Werner M, Frühauf J, Nakamura M, Christiansen H, Bremer M.
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1523-9. PubMed ID: 22526164
    [Abstract] [Full Text] [Related]

  • 2. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
    Märtens B, Janssen S, Werner M, Frühauf J, Christiansen H, Bremer M, Steinmann D.
    BMC Cancer; 2012 Oct 25; 12():497. PubMed ID: 23098039
    [Abstract] [Full Text] [Related]

  • 3. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
    Bilger A, Bretzinger E, Fennell J, Nieder C, Lorenz H, Oehlke O, Grosu AL, Specht HM, Combs SE.
    Cancer Med; 2018 Jun 25; 7(6):2350-2359. PubMed ID: 29745035
    [Abstract] [Full Text] [Related]

  • 4. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M, Pin Y, Thierry A, Clavier JB.
    Clin Exp Metastasis; 2020 Jun 25; 37(3):425-434. PubMed ID: 32185576
    [Abstract] [Full Text] [Related]

  • 5. Evaluatıon of hypofractıonated stereotactıc radıotherapy (HFSRT) to the resectıon cavıty after surgıcal resectıon of braın metastases: A sıngle center experıence.
    Dincoglan F, Sager O, Uysal B, Demiral S, Gamsiz H, Gündem E, Elcim Y, Dirican B, Beyzadeoglu M.
    Indian J Cancer; 2019 Jun 25; 56(3):202-206. PubMed ID: 31389381
    [Abstract] [Full Text] [Related]

  • 6. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A, Doré M, Cebula H, Thillays F, Proust F, Darié I, Martin SA, Delpon G, Lefebvre F, Noël G, Antoni D.
    Int J Radiat Oncol Biol Phys; 2017 Dec 01; 99(5):1179-1189. PubMed ID: 28974415
    [Abstract] [Full Text] [Related]

  • 7. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N, Leiser D, Ermis E, Vulcu S, Schucht P, Raabe A, Aebersold DM, Herrmann E.
    Radiat Oncol; 2019 Mar 14; 14(1):45. PubMed ID: 30871597
    [Abstract] [Full Text] [Related]

  • 8. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
    Waltenberger M, Bernhardt D, Diehl C, Gempt J, Meyer B, Straube C, Wiestler B, Wilkens JJ, Zimmer C, Combs SE.
    BMC Cancer; 2023 Jul 29; 23(1):709. PubMed ID: 37516835
    [Abstract] [Full Text] [Related]

  • 9. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.
    Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB.
    J Neurosurg; 2011 Jun 29; 114(6):1585-91. PubMed ID: 21166567
    [Abstract] [Full Text] [Related]

  • 10. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Do L, Pezner R, Radany E, Liu A, Staud C, Badie B.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):486-91. PubMed ID: 18922650
    [Abstract] [Full Text] [Related]

  • 11. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E, Lee JY, Thawani JP, Miller D, O'Rourke DM, Dorsey JF, Geiger GA, Nagda S, Kolker JD, Lustig RA, Alonso-Basanta M.
    J Neurosurg; 2014 Dec 01; 121 Suppl():75-83. PubMed ID: 25434940
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of adjuvant whole-brain radiotherapy versus hypofractionated stereotactic radiotherapy after surgical resection of brain metastases: a propensity score-matched analysis.
    Keller A, Lefebvre F, Ricard D, Noël G, Antoni D.
    Chin Clin Oncol; 2020 Aug 01; 9(4):55. PubMed ID: 32576020
    [Abstract] [Full Text] [Related]

  • 13. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P, Lequesne J, Barraux V, Kao W, Geffrelot J, Grellard JM, Habrand JL, Emery E, Marie B, Thariat J, Stefan D.
    Radiat Oncol; 2018 Jul 28; 13(1):138. PubMed ID: 30055640
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases.
    Bilger A, Milanovic D, Lorenz H, Oehlke O, Urbach H, Schmucker M, Weyerbrock A, Nieder C, Grosu AL.
    Clin Neurol Neurosurg; 2016 Mar 28; 142():81-86. PubMed ID: 26816106
    [Abstract] [Full Text] [Related]

  • 15. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G, Vulquin N.
    Technol Cancer Res Treat; 2018 Jan 01; 17():1533033818806498. PubMed ID: 30343637
    [Abstract] [Full Text] [Related]

  • 16. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD.
    J Neurosurg; 2017 Jul 01; 127(1):148-156. PubMed ID: 27494815
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
    Mengue L, Bertaut A, Ngo Mbus L, Doré M, Ayadi M, Clément-Colmou K, Claude L, Carrie C, Laude C, Tanguy R, Blanc J, Sunyach MP.
    Radiat Oncol; 2020 Apr 17; 15(1):82. PubMed ID: 32303236
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
    Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G.
    Radiother Oncol; 2006 Oct 17; 81(1):18-24. PubMed ID: 16978720
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
    Vigneau E, Jacquemin J, Benadon B, Dat Nguyen T, Marchand-Créty C.
    Cancer Radiother; 2021 Dec 17; 25(8):763-770. PubMed ID: 34083125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.